Top Section/Ad
Top Section/Ad
Most recent
Vincorion is expected to continue defence IPOs later this week
◆ How AI threat to software biz threatens stockmarket listings... ◆ ... and collaterlised loan obligation market ◆ AT1 market hits new record tight but buyers turn away
Early March listing set to be the latest defence sector IPO
More articles/Ad
More articles/Ad
More articles
-
Mainland-based Jacobio Pharmaceuticals has kicked off the roadshow for its Hong Kong listing. It is eyeing a valuation of up to HK$10.6bn ($1.37bn). -
Equity capital markets bankers are looking closely at knife-edge negotiations between the UK and the European Union over a possible trade agreement. They say a lack of progress on negotiations will likely stall dealmaking this week but a No Deal end to the transition period this year could also make deals more difficult from January.
-
Chinese financial technology company Bairong is targeting Hong Kong for its IPO, having filed a draft prospectus with the city’s bourse.
-
Three of France’s most famous entrepreneurs won acclaim from investors on Monday as they closed books on the IPO of 2MX Organic, a new €300m special purpose acquisition vehicle (Spac) that is seeking to shake up the European organic food sector.
-
In an extraordinary year for equity capital markets, the rising popularity of renewable energy stocks has been a prevailing theme and this momentum is continuing into year-end.
-
Harbour Biomed has pocketed HK$1.71bn ($220.8m) by pricing its IPO just above the mid point of the marketed range.
